Latest Articles
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer - FiercePharma
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer FiercePharma
Published: May 9, 2024, 7 a.m.
Paid reproductive leave 'massive win' for Queensland public servants - 9News
Paid reproductive leave 'massive win' for Queensland public servants 9News
Published: May 6, 2024, 7 a.m.
Queensland public servants to get paid leave for reproductive healthcare - ABC News
Queensland public servants to get paid leave for reproductive healthcare ABC News
Published: May 5, 2024, 7 a.m.
Bindi Irwin Shares Her Endometriosis Story in Detail as She Prepares to Receive EndoFound’s Blossom Award - Endometriosis Foundation of America - The Blossom
Bindi Irwin Shares Her Endometriosis Story in Detail as She Prepares to Receive EndoFound’s Blossom Award Endometriosis Foundation of America - The Blossom
Published: May 3, 2024, 7 a.m.
Medical Conference 2024: Elevating Sampson’s Century Legacy via Deep Dive with AI - Endometriosis Foundation of America - The Blossom
Medical Conference 2024: Elevating Sampson’s Century Legacy via Deep Dive with AI Endometriosis Foundation of America - The Blossom
Published: May 3, 2024, 7 a.m.
Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis - Reproductive Health
Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis Reproductive Health
Published: May 2, 2024, 7 a.m.
Endometriosis World Discrepancies - Bruno Van Herendael, MD - Endometriosis Foundation of America - The Blossom
Endometriosis World Discrepancies - Bruno Van Herendael, MD Endometriosis Foundation of America - The Blossom
Published: May 2, 2024, 7 a.m.
Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate - Frontiers
Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate Frontiers
Published: April 29, 2024, 7 a.m.
Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression - BioMed Central
Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression BioMed Central
Published: April 23, 2024, 7 a.m.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com
Published: April 23, 2024, 7 a.m.
Link copied to clipboard!